Adjuvant therapy of renal cell carcinoma: patient selection and therapeutic options.
Lam
John S
JS
Department of Urology, David Geffen School of Medicine at University of California-Los Angeles, Los Angeles, California 90095, USA.
Leppert
John T
JT
Belldegrun
Arie S
AS
Figlin
Robert A
RA
D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000601:surgery / Q000628:therapy*; D006360:Heat-Shock Proteins / Q000008:administration & dosage; D006801:Humans; D007680:Kidney Neoplasms / Q000601:surgery / Q000628:therapy*; D008207:Lymphatic Metastasis / Q000517:prevention & control; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D009392:Nephrectomy; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic
D000276:Adjuvants, Immunologic; D000911:Antibodies, Monoclonal; C106533:G250 monoclonal antibody; D006360:Heat-Shock Proteins